{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T10:24:37Z","timestamp":1784543077445,"version":"3.55.0"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,18]],"date-time":"2025-07-18T00:00:00Z","timestamp":1752796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,18]],"date-time":"2025-07-18T00:00:00Z","timestamp":1752796800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000957","name":"Alzheimer's Association","doi-asserted-by":"publisher","award":["23AARF-1025519"],"award-info":[{"award-number":["23AARF-1025519"]}],"id":[{"id":"10.13039\/100000957","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["GNT1162645"],"award-info":[{"award-number":["GNT1162645"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Alz Res Therapy"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Beta-amyloid (A\u03b2) plaques and tau tangles are pathological hallmarks of Alzheimer\u2019s disease (AD); however, autopsy studies reveal that most older adults also present with cerebrovascular disease (CVD) markers. It remains unclear how A\u03b2 and tau relate to cognition in the context of concurrent CVD. In initially cognitively unimpaired older adults with CVD, this study aimed to determine <jats:italic>ante-mortem<\/jats:italic> cognitive trajectories associated with elevated A\u03b2 and\/or tau at autopsy.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>Participants aged 65\u201395 classified as cognitively unimpaired at baseline from the National Alzheimer\u2019s Coordinating Center database, with \u2265\u20091 follow-up between 2005 and 2015, and available autopsy\/<jats:italic>APOE<\/jats:italic> data were included in this cohort study (<jats:italic>N<\/jats:italic>\u2009=\u2009863). All participants had at least one of six CVD markers at autopsy. Participants were classified into four groups (A\u2009\u2212\u2009T\u2212, A\u2009+\u2009T\u2212, A\u2009\u2212\u2009T+, A\u2009+\u2009T+) based on semiquantitative Consortium to Establish a Registry for Alzheimer\u2019s Disease neuritic plaque staging and Braak staging. Linear mixed models assessed rate of change in Preclinical Alzheimer\u2019s Cognitive Composite scores, episodic memory, and executive function.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>A\u2009+\u2009T\u2009+\u2009adults demonstrated significantly faster cognitive decline on all outcomes in the ~\u200910 years preceding death compared to A\u2009\u2212\u2009T\u2212 adults (d\u2009=\u20090.34\u20130.46). Similarly, when compared to A\u2009+\u2009T\u2009\u2212\u2009adults, A\u2009+\u2009T\u2009+\u2009adults showed significantly faster decline on all outcomes (d\u2009=\u20090.19\u20130.37). At the last visit prior to death, a greater proportion of A\u2009+\u2009T\u2009+\u2009adults (36%) received a dementia diagnosis compared to A\u2009\u2212\u2009T+ (15%; OR\u2009=\u20096.00), A\u2009+\u2009T\u2212 (14%; OR\u2009=\u20098.00) and A\u2009\u2212\u2009T\u2212 adults (12%; OR\u2009=\u20096.86), <jats:italic>p<\/jats:italic>\u2009&lt;.001. When analyses were restricted to exclude dementia diagnoses, significantly faster decline on all outcomes (<jats:italic>p<\/jats:italic>\u2019s\u2009&lt;\u20090.001, d\u2009=\u20090.29\u20130.37) was similarly observed in A\u2009+\u2009T\u2009+\u2009adults compared to A\u2009\u2212\u2009T\u2212 adults.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>In older adults with concurrent CVD, A\u2009+\u2009T\u2009+\u2009at autopsy was associated with greater cognitive decline over 10 years preceding death compared to A\u2009\u2212\u2009T\u2212 older adults. Faster cognitive decline in A\u2009+\u2009T\u2009+\u2009in the context of low final visit dementia diagnoses may suggest that <jats:italic>post-mortem<\/jats:italic> A\u2009+\u2009T\u2009+\u2009is associated with a steep trajectory of cognitive decline <jats:italic>ante-mortem<\/jats:italic>, but that dementia progression is not inevitable.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s13195-025-01776-w","type":"journal-article","created":{"date-parts":[[2025,7,18]],"date-time":"2025-07-18T10:25:35Z","timestamp":1752834335000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Ante-mortem cognitive trajectories associated with A\u03b2 and tau biomarker profiles in older adults with cerebrovascular disease: a longitudinal cohort study"],"prefix":"10.1186","volume":"17","author":[{"given":"Emily","family":"Rosenich","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yen Ying","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"on behalf of the National Alzheimer\u2019s Coordinating Center","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,18]]},"reference":[{"issue":"4","key":"1776_CR1","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","volume":"14","author":"CR Jack Jr","year":"2018","unstructured":"Jack CR Jr, Bennett DA, Blennow K, Carrillo MC, Dunn B, Haeberlein SB, et al. NIA-AA research framework: toward a biological definition of alzheimer\u2019s disease. Alzheimer\u2019s Dement. 2018;14(4):535\u201362.","journal-title":"Alzheimer\u2019s Dement"},{"issue":"8","key":"1776_CR2","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1016\/j.jalz.2018.03.005","volume":"14","author":"R Brookmeyer","year":"2018","unstructured":"Brookmeyer R, Abdalla N. Estimation of lifetime risks of alzheimer\u2019s disease dementia using biomarkers for preclinical disease. Alzheimer\u2019s Dement. 2018;14(8):981\u20138.","journal-title":"Alzheimer\u2019s Dement"},{"issue":"3","key":"1776_CR3","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.jalz.2011.03.003","volume":"7","author":"RA Sperling","year":"2011","unstructured":"Sperling RA, Aisen PS, Beckett LA, Bennett DA, Craft S, Fagan AM, et al. Toward defining the preclinical stages of alzheimer\u2019s disease: recommendations from the National Institute on Aging-Alzheimer\u2019s association workgroups on diagnostic guidelines for alzheimer\u2019s disease. Alzheimer\u2019s Dement. 2011;7(3):280\u201392.","journal-title":"Alzheimer\u2019s Dement"},{"issue":"14","key":"1776_CR4","doi-asserted-by":"publisher","first-page":"e1567","DOI":"10.1212\/WNL.0000000000007248","volume":"92","author":"A Soldan","year":"2019","unstructured":"Soldan A, Pettigrew C, Fagan AM, Schindler SE, Moghekar A, Fowler C, et al. ATN profiles among cognitively normal individuals and longitudinal cognitive outcomes. Neurology. 2019;92(14):e1567\u201379.","journal-title":"Neurology"},{"issue":"23","key":"1776_CR5","doi-asserted-by":"publisher","first-page":"2316","DOI":"10.1001\/jama.2019.7437","volume":"321","author":"CR Jack Jr","year":"2019","unstructured":"Jack CR Jr, Wiste HJ, Therneau TM, Weigand SD, Knopman DS, Mielke MM, et al. Associations of amyloid, tau, and neurodegeneration biomarker profiles with rates of memory decline among individuals without dementia. JAMA. 2019;321(23):2316\u201325.","journal-title":"JAMA"},{"issue":"9","key":"1776_CR6","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1016\/j.jalz.2019.05.006","volume":"15","author":"J-T Yu","year":"2019","unstructured":"Yu J-T, Li J-Q, Suckling J, Feng L, Pan A, Wang Y-J, et al. Frequency and longitudinal clinical outcomes of alzheimer\u2019s AT(N) biomarker profiles: A longitudinal study. Alzheimer\u2019s Dement. 2019;15(9):1208\u201317.","journal-title":"Alzheimer\u2019s Dement"},{"issue":"1","key":"1776_CR7","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.jalz.2018.07.222","volume":"15","author":"MD Sweeney","year":"2019","unstructured":"Sweeney MD, Montagne A, Sagare AP, Nation DA, Schneider LS, Chui HC, et al. Vascular dysfunction\u2014the disregarded partner of alzheimer\u2019s disease. Alzheimer\u2019s Dement. 2019;15(1):158\u201367.","journal-title":"Alzheimer\u2019s Dement"},{"issue":"24","key":"1776_CR8","doi-asserted-by":"publisher","first-page":"2197","DOI":"10.1212\/01.wnl.0000271090.28148.24","volume":"69","author":"JA Schneider","year":"2007","unstructured":"Schneider JA, Arvanitakis Z, Bang W, Bennett DA. Mixed brain pathologies account for most dementia cases in community-dwelling older persons. Neurology. 2007;69(24):2197\u2013204.","journal-title":"Neurology"},{"issue":"1","key":"1776_CR9","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1002\/ana.25380","volume":"85","author":"PA Boyle","year":"2019","unstructured":"Boyle PA, Yu L, Leurgans SE, Wilson RS, Brookmeyer R, Schneider JA, et al. Attributable risk of alzheimer\u2019s dementia attributed to age-related neuropathologies. Ann Neurol. 2019;85(1):114\u201324.","journal-title":"Ann Neurol"},{"issue":"3","key":"1776_CR10","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1093\/brain\/awu393","volume":"138","author":"P Vemuri","year":"2015","unstructured":"Vemuri P, Lesnick TG, Przybelski SA, Knopman DS, Preboske GM, Kantarci K, et al. Vascular and amyloid pathologies are independent predictors of cognitive decline in normal elderly. Brain. 2015;138(3):761\u201371.","journal-title":"Brain"},{"issue":"1","key":"1776_CR11","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1002\/ana.21142","volume":"62","author":"JA Schneider","year":"2007","unstructured":"Schneider JA, Boyle PA, Arvanitakis Z, Bienias JL, Bennett DA. Subcortical infarcts, alzheimer\u2019s disease pathology, and memory function in older persons. Ann Neurol. 2007;62(1):59\u201366.","journal-title":"Ann Neurol"},{"key":"1776_CR12","doi-asserted-by":"crossref","unstructured":"Laing KK, Simoes S, Baena-Caldas GP, Lao PJ, Kothiya M, Igwe KC et al. Cerebrovascular disease promotes Tau pathology in alzheimer\u2019s disease. Brain Commun. 2020;2(2).","DOI":"10.1093\/braincomms\/fcaa132"},{"key":"1776_CR13","doi-asserted-by":"crossref","unstructured":"Weigand AJ, Bangen KJ, Thomas KR, Delano-Wood L, Gilbert PE, Brickman AM et al. Is Tau in the absence of amyloid on the alzheimer\u2019s continuum? A study of discordant PET positivity. Brain Commun. 2019;2(1).","DOI":"10.1093\/braincomms\/fcz046"},{"key":"1776_CR14","doi-asserted-by":"crossref","unstructured":"Weigand AJ, Edwards L, Thomas KR, Bangen KJ, Bondi MW, Initiative ftAsDN. Comprehensive characterization of elevated Tau PET signal in the absence of amyloid-beta. Brain Commun. 2022;4(6).","DOI":"10.1093\/braincomms\/fcac272"},{"issue":"1","key":"1776_CR15","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1186\/s12916-014-0206-2","volume":"12","author":"J Attems","year":"2014","unstructured":"Attems J, Jellinger KA. The overlap between vascular disease and alzheimer\u2019s disease - lessons from pathology. BMC Med. 2014;12(1):206.","journal-title":"BMC Med"},{"issue":"1","key":"1776_CR16","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1161\/STROKEAHA.121.034814","volume":"53","author":"M Lamar","year":"2022","unstructured":"Lamar M, Leurgans S, Kapasi A, Barnes LL, Boyle PA, Bennett DA, et al. Complex profiles of cerebrovascular disease pathologies in the aging brain and their relationship with cognitive decline. Stroke. 2022;53(1):218\u201327.","journal-title":"Stroke"},{"issue":"3","key":"1776_CR17","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1212\/WNL.0b013e3181cb3e25","volume":"74","author":"RC Petersen","year":"2010","unstructured":"Petersen RC, Aisen PS, Beckett LA, Donohue MC, Gamst AC, Harvey DJ, et al. Alzheimer\u2019s disease neuroimaging initiative (ADNI): clinical characterization. Neurology. 2010;74(3):201\u20139.","journal-title":"Neurology"},{"issue":"4","key":"1776_CR18","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1017\/S1041610209009405","volume":"21","author":"K Ellis","year":"2009","unstructured":"Ellis K, Bush A, Darby D, De Fazio D, Foster J, Hudson P, et al. The Australian imaging, biomarkers and lifestyle (AIBL) study of aging: methodology and baseline characteristics of 1112 individuals recruited for a longitudinal study of alzheimer\u2019s disease. Int Psychgeriatrics. 2009;21(4):672\u201387.","journal-title":"Int Psychgeriatrics"},{"issue":"15","key":"1776_CR19","doi-asserted-by":"publisher","first-page":"e1402","DOI":"10.1212\/WNL.0000000000006310","volume":"91","author":"AM Brickman","year":"2018","unstructured":"Brickman AM, Tosto G, Gutierrez J, Andrews H, Gu Y, Narkhede A, et al. An MRI measure of degenerative and cerebrovascular pathology in alzheimer disease. Neurology. 2018;91(15):e1402\u201312.","journal-title":"Neurology"},{"issue":"1","key":"1776_CR20","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1002\/ana.20318","volume":"57","author":"H Petrovitch","year":"2005","unstructured":"Petrovitch H, Ross GW, Steinhorn SC, Abbott RD, Markesbery W, Davis D, et al. AD lesions and infarcts in demented and non-demented Japanese\u2010American men. Annals Neurology: Official J Am Neurol Association Child Neurol Soc. 2005;57(1):98\u2013103.","journal-title":"Annals Neurology: Official J Am Neurol Association Child Neurol Soc"},{"issue":"1","key":"1776_CR21","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1177\/23969873211000258","volume":"6","author":"A Verdelho","year":"2021","unstructured":"Verdelho A, Wardlaw J, Pavlovic A, Pantoni L, Godefroy O, Duering M, et al. Cognitive impairment in patients with cerebrovascular disease: a white paper from the links between stroke ESO dementia committee. Eur Stroke J. 2021;6(1):5\u201317.","journal-title":"Eur Stroke J"},{"issue":"7","key":"1776_CR22","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/s41582-018-0014-y","volume":"14","author":"A ter Telgte","year":"2018","unstructured":"ter Telgte A, van Leijsen EMC, Wiegertjes K, Klijn CJM, Tuladhar AM, de Leeuw F-E. Cerebral small vessel disease: from a focal to a global perspective. Nat Reviews Neurol. 2018;14(7):387\u201398.","journal-title":"Nat Reviews Neurol"},{"key":"1776_CR23","doi-asserted-by":"publisher","first-page":"111184","DOI":"10.1016\/j.pscychresns.2020.111184","volume":"306","author":"A Badji","year":"2020","unstructured":"Badji A, Westman E. Cerebrovascular pathology in alzheimer\u2019s disease: hopes and gaps. Psychiatry Research: Neuroimaging. 2020;306:111184.","journal-title":"Psychiatry Research: Neuroimaging"},{"issue":"4","key":"1776_CR24","doi-asserted-by":"publisher","first-page":"330","DOI":"10.2174\/156720511795745348","volume":"8","author":"I Driscoll","year":"2011","unstructured":"Driscoll I, Troncoso J. Asymptomatic alzheimer\u2019s disease: a prodrome or a state of resilience? Curr Alzheimer Res. 2011;8(4):330\u20135.","journal-title":"Curr Alzheimer Res"},{"key":"1776_CR25","doi-asserted-by":"crossref","unstructured":"Besser L, Kukull W, Knopman DS, Chui H, Galasko D, Weintraub S, et al. Version 3 of the National alzheimer\u2019s coordinating center\u2019s uniform data set. Alzheimer Dis Assoc Disord; 2018.","DOI":"10.1097\/WAD.0000000000000279"},{"issue":"2","key":"1776_CR26","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1097\/WAD.0b013e318191c7dd","volume":"23","author":"S Weintraub","year":"2009","unstructured":"Weintraub S, Salmon D, Mercaldo N, Ferris S, Graff-Radford NR, Chui H, et al. The alzheimer\u2019s disease centers\u2019 uniform data set (UDS): the neuropsychological test battery. Alzheimer Dis Assoc Disord. 2009;23(2):91.","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"1776_CR27","doi-asserted-by":"crossref","unstructured":"Morris JC, Weintraub S, Chui HC, Cummings J, DeCarli C, Ferris S, et al. Alzheimer Disease Assoc Disorders. 2006;20(4):210\u20136. The Uniform Data Set (UDS): clinical and cognitive variables and descriptive data from Alzheimer Disease Centers.","DOI":"10.1097\/01.wad.0000213865.09806.92"},{"issue":"2","key":"1776_CR28","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1097\/WAD.0000000000000376","volume":"34","author":"JE Culhane","year":"2020","unstructured":"Culhane JE, Chan KCG, Teylan MA, Chen Y-C, Mock C, Gauthreaux K, et al. Factor consistency of neuropsychological test battery versions in the NACC uniform data set. Alzheimer Disease Assoc Disorders. 2020;34(2):175\u20137.","journal-title":"Alzheimer Disease Assoc Disorders"},{"issue":"1","key":"1776_CR29","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.gerinurse.2020.08.016","volume":"42","author":"S Ahn","year":"2021","unstructured":"Ahn S, Mathiason MA, Lindquist R, Yu F. Factors predicting episodic memory changes in older adults with subjective cognitive decline: A longitudinal observational study. Geriatr Nurs. 2021;42(1):268\u201375.","journal-title":"Geriatr Nurs"},{"issue":"4","key":"1776_CR30","doi-asserted-by":"publisher","first-page":"e322","DOI":"10.1212\/WNL.0000000000007831","volume":"93","author":"PS Insel","year":"2019","unstructured":"Insel PS, Weiner M, Mackin RS, Mormino E, Lim YY, Stomrud E, et al. Determining clinically meaningful decline in preclinical alzheimer disease. Neurology. 2019;93(4):e322.","journal-title":"Neurology"},{"issue":"4","key":"1776_CR31","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1002\/alz.12214","volume":"17","author":"AM Staffaroni","year":"2021","unstructured":"Staffaroni AM, Asken BM, Casaletto KB, Fonseca C, You M, Rosen HJ, et al. Development and validation of the uniform data set (v3. 0) executive function composite score (UDS3-EF). Alzheimer\u2019s Dement. 2021;17(4):574\u201383.","journal-title":"Alzheimer\u2019s Dement"},{"issue":"8","key":"1776_CR32","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1093\/jnen\/nly049","volume":"77","author":"LM Besser","year":"2018","unstructured":"Besser LM, Kukull WA, Teylan MA, Bigio EH, Cairns NJ, Kofler JK, et al. The revised National alzheimer\u2019s coordinating center\u2019s neuropathology Form\u2014Available data and new analyses. J Neuropathology Experimental Neurol. 2018;77(8):717\u201326.","journal-title":"J Neuropathology Experimental Neurol"},{"issue":"9","key":"1776_CR33","doi-asserted-by":"publisher","first-page":"2501","DOI":"10.1016\/j.neurobiolaging.2015.05.021","volume":"36","author":"TJ Hohman","year":"2015","unstructured":"Hohman TJ, Samuels LR, Liu D, Gifford KA, Mukherjee S, Benson EM, et al. Stroke risk interacts with alzheimer\u2019s disease biomarkers on brain aging outcomes. Neurobiol Aging. 2015;36(9):2501\u20138.","journal-title":"Neurobiol Aging"},{"issue":"4","key":"1776_CR34","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.3233\/JAD-191023","volume":"73","author":"C Xu","year":"2020","unstructured":"Xu C, Apostolova LG, Oblak AL, Gao S. Association of hypercholesterolemia with alzheimer\u2019s disease pathology and cerebral amyloid angiopathy. J Alzheimers Dis. 2020;73(4):1305\u201311.","journal-title":"J Alzheimers Dis"},{"key":"1776_CR35","doi-asserted-by":"crossref","unstructured":"Cohen J. Statistical power analysis for the behavioral sciences. Academic; 2013.","DOI":"10.4324\/9780203771587"},{"issue":"7","key":"1776_CR36","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1002\/alz.12480","volume":"18","author":"D Tosun","year":"2022","unstructured":"Tosun D, Demir Z, Veitch DP, Weintraub D, Aisen P, Jack CR Jr., et al. Contribution of alzheimer\u2019s biomarkers and risk factors to cognitive impairment and decline across the alzheimer\u2019s disease continuum. Alzheimers Dement. 2022;18(7):1370\u201382.","journal-title":"Alzheimers Dement"},{"issue":"12","key":"1776_CR37","doi-asserted-by":"publisher","first-page":"3286","DOI":"10.1093\/brain\/awx243","volume":"140","author":"A Bejanin","year":"2017","unstructured":"Bejanin A, Schonhaut DR, La Joie R, Kramer JH, Baker SL, Sosa N, et al. Tau pathology and neurodegeneration contribute to cognitive impairment in alzheimer\u2019s disease. Brain. 2017;140(12):3286\u2013300.","journal-title":"Brain"},{"issue":"9","key":"1776_CR38","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1212\/WNL.42.9.1681","volume":"42","author":"PV Arriagada","year":"1992","unstructured":"Arriagada PV, Marzloff K, Hyman BT. Distribution of Alzheimer-type pathologic changes in nondemented elderly individuals matches the pattern in alzheimer\u2019s disease. Neurology. 1992;42(9):1681\u20138.","journal-title":"Neurology"},{"issue":"5","key":"1776_CR39","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1097\/NEN.0b013e31825018f7","volume":"71","author":"PT Nelson","year":"2012","unstructured":"Nelson PT, Alafuzoff I, Bigio EH, Bouras C, Braak H, Cairns NJ, et al. Correlation of alzheimer disease neuropathologic changes with cognitive status: a review of the literature. J Neuropathology Experimental Neurol. 2012;71(5):362\u201381.","journal-title":"J Neuropathology Experimental Neurol"},{"issue":"6","key":"1776_CR40","doi-asserted-by":"publisher","first-page":"e601","DOI":"10.1212\/WNL.0000000000006875","volume":"92","author":"R Ossenkoppele","year":"2019","unstructured":"Ossenkoppele R, Smith R, Ohlsson T, Strandberg O, Mattsson N, Insel PS, et al. Associations between tau, A\u03b2, and cortical thickness with cognition in alzheimer disease. Neurology. 2019;92(6):e601\u201312.","journal-title":"Neurology"},{"issue":"2","key":"1776_CR41","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1002\/ana.25395","volume":"85","author":"RA Sperling","year":"2019","unstructured":"Sperling RA, Mormino EC, Schultz AP, Betensky RA, Papp KV, Amariglio RE, et al. The impact of amyloid-beta and Tau on prospective cognitive decline in older individuals. Ann Neurol. 2019;85(2):181\u201393.","journal-title":"Ann Neurol"},{"issue":"1","key":"1776_CR42","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1093\/brain\/awz378","volume":"143","author":"TJ Betthauser","year":"2019","unstructured":"Betthauser TJ, Koscik RL, Jonaitis EM, Allison SL, Cody KA, Erickson CM, et al. Amyloid and Tau imaging biomarkers explain cognitive decline from late middle-age. Brain. 2019;143(1):320\u201335.","journal-title":"Brain"},{"issue":"8","key":"1776_CR43","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1001\/jamaneurol.2019.1424","volume":"76","author":"BJ Hanseeuw","year":"2019","unstructured":"Hanseeuw BJ, Betensky RA, Jacobs HI, Schultz AP, Sepulcre J, Becker JA, et al. Association of amyloid and Tau with cognition in preclinical alzheimer disease: a longitudinal study. JAMA Neurol. 2019;76(8):915\u201324.","journal-title":"JAMA Neurol"},{"issue":"11","key":"1776_CR44","doi-asserted-by":"publisher","first-page":"2381","DOI":"10.1038\/s41591-022-02049-x","volume":"28","author":"R Ossenkoppele","year":"2022","unstructured":"Ossenkoppele R, Pichet Binette A, Groot C, Smith R, Strandberg O, Palmqvist S, et al. Amyloid and Tau PET-positive cognitively unimpaired individuals are at high risk for future cognitive decline. Nat Med. 2022;28(11):2381\u20137.","journal-title":"Nat Med"},{"issue":"1","key":"1776_CR45","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1002\/ana.25246","volume":"84","author":"MC Power","year":"2018","unstructured":"Power MC, Mormino E, Soldan A, James BD, Yu L, Armstrong NM, et al. Combined neuropathological pathways account for age-related risk of dementia. Ann Neurol. 2018;84(1):10\u201322.","journal-title":"Ann Neurol"},{"key":"1776_CR46","doi-asserted-by":"crossref","unstructured":"Wattmo C, Wallin A. Early-versus late-onset Alzheimer\u2019s disease in clinical practice: cognitive and global outcomes over 3 years. Alzheimers Res Ther. 2017; 9 (1): 70. 2017.","DOI":"10.1186\/s13195-017-0294-2"},{"issue":"1","key":"1776_CR47","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1002\/ana.25123","volume":"83","author":"PA Boyle","year":"2018","unstructured":"Boyle PA, Yu L, Wilson RS, Leurgans SE, Schneider JA, Bennett DA. Person-specific contribution of neuropathologies to cognitive loss in old age. Ann Neurol. 2018;83(1):74\u201383.","journal-title":"Ann Neurol"},{"issue":"4","key":"1776_CR48","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/S1474-4422(18)30029-2","volume":"17","author":"B Dubois","year":"2018","unstructured":"Dubois B, Epelbaum S, Nyasse F, Bakardjian H, Gagliardi G, Uspenskaya O, et al. Cognitive and neuroimaging features and brain \u03b2-amyloidosis in individuals at risk of alzheimer\u2019s disease (INSIGHT-preAD): a longitudinal observational study. Lancet Neurol. 2018;17(4):335\u201346.","journal-title":"Lancet Neurol"},{"key":"1776_CR49","first-page":"1","volume":"Preprint","author":"L Edwards","year":"2023","unstructured":"Edwards L, Thomas KR, Weigand AJ, Edmonds EC, Clark AL, Walker KS, et al. White matter hyperintensity volume and Amyloid-PET synergistically impact memory independent of Tau-PET in older adults without dementia. J Alzheimers Dis. 2023;Preprint:1\u201313.","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"1776_CR50","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1136\/jnnp-2023-331603","volume":"95","author":"MY Chun","year":"2024","unstructured":"Chun MY, Jang H, Kim S-J, Park YH, Yun J, Lockhart SN, et al. Emerging role of vascular burden in AT (N) classification in individuals with alzheimer\u2019s and concomitant cerebrovascular burdens. J Neurol Neurosurg Psychiatry. 2024;95(1):44\u201351.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"10","key":"1776_CR51","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1001\/jama.1997.03540340047031","volume":"277","author":"DA Snowdon","year":"1997","unstructured":"Snowdon DA, Greiner LH, Mortimer JA, Riley KP, Greiner PA, Markesbery WR. Brain infarction and the clinical expression of alzheimer disease: the Nun study. JAMA. 1997;277(10):813\u20137.","journal-title":"JAMA"},{"issue":"4","key":"1776_CR52","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1001\/jamaneurol.2013.5847","volume":"71","author":"GS Bloom","year":"2014","unstructured":"Bloom GS. Amyloid-\u03b2 and tau: the trigger and bullet in alzheimer disease pathogenesis. JAMA Neurol. 2014;71(4):505\u20138.","journal-title":"JAMA Neurol"},{"issue":"10","key":"1776_CR53","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1038\/s41593-020-0687-6","volume":"23","author":"MA Busche","year":"2020","unstructured":"Busche MA, Hyman BT. Synergy between amyloid-\u03b2 and Tau in alzheimer\u2019s disease. Nat Neurosci. 2020;23(10):1183\u201393.","journal-title":"Nat Neurosci"},{"key":"1776_CR54","doi-asserted-by":"publisher","first-page":"e49132","DOI":"10.7554\/eLife.49132","volume":"8","author":"JN Adams","year":"2019","unstructured":"Adams JN, Maass A, Harrison TM, Baker SL, Jagust WJ. Cortical Tau deposition follows patterns of entorhinal functional connectivity in aging. Elife. 2019;8:e49132.","journal-title":"Elife"},{"issue":"3","key":"1776_CR55","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1093\/brain\/awad317","volume":"147","author":"EM Coomans","year":"2024","unstructured":"Coomans EM, van Westen D, Binette AP, Strandberg O, Spotorno N, Serrano GE, et al. Interactions between vascular burden and amyloid-\u03b2 pathology on trajectories of Tau accumulation. Brain. 2024;147(3):949\u201360.","journal-title":"Brain"},{"issue":"10","key":"1776_CR56","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.1016\/j.neuropsychologia.2009.03.004","volume":"47","author":"Y Stern","year":"2009","unstructured":"Stern Y. Cognitive reserve. Neuropsychologia. 2009;47(10):2015\u201328.","journal-title":"Neuropsychologia"},{"issue":"1","key":"1776_CR57","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1002\/alz.13422","volume":"20","author":"K Gauthreaux","year":"2024","unstructured":"Gauthreaux K, Kukull WA, Nelson KB, Mock C, Chen YC, Chan KC, et al. Different cohort, disparate results: selection bias is a key factor in autopsy cohorts. Alzheimer\u2019s Dement. 2024;20(1):266\u201377.","journal-title":"Alzheimer\u2019s Dement"}],"container-title":["Alzheimer's Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-025-01776-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13195-025-01776-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-025-01776-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T15:39:58Z","timestamp":1757259598000},"score":1,"resource":{"primary":{"URL":"https:\/\/alzres.biomedcentral.com\/articles\/10.1186\/s13195-025-01776-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,18]]},"references-count":57,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1776"],"URL":"https:\/\/doi.org\/10.1186\/s13195-025-01776-w","relation":{},"ISSN":["1758-9193"],"issn-type":[{"value":"1758-9193","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,18]]},"assertion":[{"value":"19 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The University of Washington Institutional Review Board approves all research using the NACC database and ethical approval was also obtained from individual ADRC\u2019s Institutional Review Boards. Written informed consent was obtained from all participants and informants..","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"165"}}